A lower appeals court ruling allowing human genes to be patented has been overturned by the U.S. Supreme Court, which sends the case back down for a continuation of the battle between those who believe that genes carrying the secrets of life should not be exploited for commercial gain and companies who argue that a patent must be the reward for years of expensive research that moves science forward.
The ruling again overturns patents belonging to Myriad Genetics Inc. of Salt Lake City on two genes linked to increased risk of breast and ovarian cancer. Myriad's BRACAnalysis test looks for mutations on the breast cancer predisposition gene, or BRCA. Now they must go back for a rehearing and the impact could be substantial.
The U.S. Patent and Trademark Office has been awarding patents on human genes for almost 30 years.
The case is Association for Molecular Pathology v. Myriad Genetics, 11-725.
Supreme Court throws out human gene patents, Associated Press, Monday, March 26, 2012
- PHYSICAL SCIENCES
- EARTH SCIENCES
- LIFE SCIENCES
- SOCIAL SCIENCES
Subscribe to the newsletter
Stay in touch with the scientific world!
Know Science And Want To Write?
- Traditional Medicine: Thunder God Vine As Potential Obesity Treatment
- Could Better Psychology Tests Have Predicted The Germanwings Suicide Crash?
- Numenta And IBM To Build Biologically Inspired Intelligent Machines.
- American Indian Students Disproportionately Disciplined Compared To White Students
- Antidepressants More Effective Than Assumed
- "Boys With Toys" - Was It Sexist?
- New Project Aims to Establish a Human Colony on Mars
- "I like that Tolle does not focus on the usual pseudo psychology and blame traumatic events in the..."
- "Just released on the subject and favoring the view I expressed so poorly http://www.ipmu.jp/node/21..."
- "You are seeing firsthand what we have been up against. I just want to say to some of these people..."
- "Ok thanks...."
- "Well I don't know what the background or the reason for it is, but when I did the google scholar..."